• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Pooled Analysis of Five-Year Data from Two Phase 3 Studies Further Supports Overall Survival Advantage Observed in Patients with Myelofibrosis Treated With Jakafi® (ruxolitinib)

    Pooled Analysis of Five-Year Data from Two Phase 3 Studies Further Supports Overall Survival Advantage Observed in Patients with Myelofibrosis Treated With Jakafi® (ruxolitinib)

  2. Global Veterinary Healthcare Market Report 2015-2020 - Analysis, Technologies & Forecasts - Vendors: Zoetis Animal Healthcare, Merck, Novartis - Research and Markets

    Global Veterinary Healthcare Market Report 2015-2020 - Analysis, Technologies & Forecasts - Vendors: Zoetis Animal Healthcare, Merck, Novartis - Research and Markets

  3. UPDATE: Can't afford to buy a home in San Francisco? Move here

    UPDATE: Can't afford to buy a home in San Francisco? Move here

  4. Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

    Global Hepatitis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2020 - Research and Markets

  5. Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Research and Markets

    Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Research and Markets

  6. Alnylam Reports Positive Interim Clinical Results for Fitusiran from Ongoing Phase 2 Open Label Extension Study in Patients with Hemophilia A or B without Inhibitors

    Alnylam Reports Positive Interim Clinical Results for Fitusiran from Ongoing Phase 2 Open Label Extension Study in Patients with Hemophilia A or B without Inhibitors

  7. Fondation IPSEN Colloques médecine et recherche: Endocrinology

    Fondation IPSEN Colloques médecine et recherche: Endocrinology

  8. Drops for Italian banks pull European stocks into the red

    Drops for Italian banks pull European stocks into the red

  9. Behcet Disease Global Clinical Trials Review, H2, 2016 - Research and Markets

    Behcet Disease Global Clinical Trials Review, H2, 2016 - Research and Markets

  10. Global Pancreatic Cancer Therapeutics & Diagnostics Market Report 2015-2020 - Analysis, Technologies & Forecasts - Vendors: Amgen, Incyte Corp, Roche - Research and Markets

    Global Pancreatic Cancer Therapeutics & Diagnostics Market Report 2015-2020 - Analysis, Technologies & Forecasts - Vendors: Amgen, Incyte Corp, Roche - Research and Markets

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.